Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vimentin-positive invasive breast carcinoma of no special type: A breast carcinoma with lethal biological characteristics.
Ichinose Y, Hasebe T, Hirasaki M, Sakakibara A, Yokogawa H, Nukui A, Hiratsuka M, Fujimoto A, Iso C, Wakui N, Shibasaki S, Kamada K, Suzuki N, Kamakura Y, Yasuda M, Aya A, Shimada H, Matsuura K, Ishiguro H, Osaki A, Saeki T. Ichinose Y, et al. Among authors: sakakibara a. Pathol Int. 2023 Sep;73(9):413-433. doi: 10.1111/pin.13350. Epub 2023 Jun 28. Pathol Int. 2023. PMID: 37378453
Tumor budding and fibrotic focus-proposed grading system for tumor budding in invasive carcinoma no special type of the breast.
Hiratsuka M, Hasebe T, Ichinose Y, Sakakibara A, Fujimoto A, Wakui N, Shibasaki S, Hirasaki M, Yasuda M, Nukui A, Shimada H, Yokogawa H, Matsuura K, Hojo T, Osaki A, Saeki T. Hiratsuka M, et al. Among authors: sakakibara a. Virchows Arch. 2022 Aug;481(2):161-190. doi: 10.1007/s00428-022-03337-0. Epub 2022 Jun 13. Virchows Arch. 2022. PMID: 35695928 Free PMC article.
Correction to: Tumor budding and fibrotic focus-proposed grading system for tumor budding in invasive carcinoma no special type of the breast.
Hiratsuka M, Hasebe T, Ichinose Y, Sakakibara A, Fujimoto A, Wakui N, Shibasaki S, Hirasaki M, Yasuda M, Nukui A, Shimada H, Yokogawa H, Matsuura K, Hojo T, Osaki A, Saeki T. Hiratsuka M, et al. Among authors: sakakibara a. Virchows Arch. 2024 May;484(5):873. doi: 10.1007/s00428-022-03486-2. Virchows Arch. 2024. PMID: 36580139 Free PMC article. No abstract available.
Clinicopathological prognostic characteristics and long‑term outcomes of patients with breast cancer and collagen disorder in comparison to those without collagen disorder.
Matsuura K, Osaki A, Ichinose Y, Fujimoto A, Sakakibara A, Nukui A, Yokogawa H, Shimada H, Asano A, Ohara M, Ishiguro H, Takahashi T, Saeki T. Matsuura K, et al. Among authors: sakakibara a. Oncol Lett. 2023 Sep 29;26(5):495. doi: 10.3892/ol.2023.14082. eCollection 2023 Nov. Oncol Lett. 2023. PMID: 37854859 Free PMC article.
Effect of Statins on Patients With Osteoradionecrosis of the Jaw.
Kusumoto J, Muraki Y, Sakakibara A, Furudoi S, Akashi M. Kusumoto J, et al. Among authors: sakakibara a. J Oral Maxillofac Surg. 2024 Dec;82(12):1585-1595. doi: 10.1016/j.joms.2024.08.002. Epub 2024 Aug 10. J Oral Maxillofac Surg. 2024. PMID: 39208868
Effect of Frequent Computed Tomography Examinations with Contrast Media on the Renal Function of Patients with Oral Squamous Cell Cancer and an Evaluation of Risk Factors for Post-Operative Chronic Kidney Disease.
Hasegawa T, Matsuda A, Amano R, Saito I, Takeda D, Kakei Y, Kimoto A, Sakakibara A, Akashi M. Hasegawa T, et al. Among authors: sakakibara a. J Maxillofac Oral Surg. 2024 Aug;23(4):824-830. doi: 10.1007/s12663-023-02015-1. Epub 2023 Sep 27. J Maxillofac Oral Surg. 2024. PMID: 39118931
234 results